SignalXSignalX

CVRx, Inc. (CVRX) 8-K Current Report: March 3, 2026

Filed: March 3, 2026
Health Care
Surgical & Medical Instruments & Apparatus
CVRx, Inc. Overview

CVRx, Inc. (CVRX) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 5.02: Departure/Election of Directors or Officers

CVRx, Inc. 8-K Mar 3, 2026 Event Analysis

Item 5.02 · Departure/Election of Directors or Officers

  • • PSU awards granted to all executive officers Feb 27, 2026 at 75% of annual LTI value — significant incremental retention-focused grant
  • • Vesting tied to undisclosed cumulative 2026-2027 revenue goal; payout range 50% of target (threshold) to 200% of target (maximum)
  • • Settlement split: 50% after performance certification post-2027, remaining 50% on Dec 31, 2028 — extends retention window through end of 2028
  • • Change-of-control provision converts PSUs to time-based RSUs at greater of target or actual performance — protects upside in acquisition scenario
  • • Undisclosed revenue target limits investor ability to gauge likelihood of payout; Committee describes it only as "meaningful revenue growth"

Get deeper insights on CVRx, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.